Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Cell Physiol Biochem ; 13(6): 329-36, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14631139

RESUMEN

The effect of phenazine methosulphate (PMS; 1 mM) on (86Rb+) K+ transport in human red cells was investigated to ascertain its action on the K+-Cl- cotransporter (KCC; defined as the Cl- dependent component of K+ flux measured in the presence of ouabain and bumetanide) and the Ca2+-activated K+ channel (Gardos channel; defined as the clotrimazole, 5 microM, -sensitive K+ flux). In the presence of Ca2+, both transport pathways were stimulated but effects were markedly greater under deoxygenated conditions (5-fold for KCC; 20-fold for the Gardos channel). KCC activation was inhibited by prior treatment with calyculin A (100 nM), implying action via protein dephosphorylation. Activation of the Gardos channel correlated with 28 +/- 3% inhibition of the plasma membrane Ca2+ pump, with maximal activity reduced from 7.7 +/- 1.1 to 2.7 +/- 0.7 micromol.(l cells.h)(-1) (all means +/- S.E.M. for n = 3), and a 3-fold increase in sensitivity of the channel to Ca2+ (EC50 reduced from 437 +/- 156 to 152 +/- 57 nM). Increased availability of NADH in deoxygenated conditions, resulting in increased free radical generation by PMS, may be responsible. We speculate that the similarity of the K+ transport phenotype produced by PMS to that seen in deoxygenated sickle cells is relevant to the pathophysiology of sickle cell disease.


Asunto(s)
Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Metosulfato de Metilfenazonio/farmacología , Potasio/metabolismo , Calcio/metabolismo , Calcio/farmacología , Humanos , Transporte Iónico/efectos de los fármacos , Fosfoproteínas Fosfatasas/antagonistas & inhibidores , Fosfoproteínas Fosfatasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA